Symbol | Exchange | Currency |
|---|
Investing.com – U.S. stocks were higher after the close on Tuesday, as gains in the Technology, Consumer Services and Oil & Gas sectors led shares higher. At the close in NYSE,...
Investing.com – U.S. stocks were mixed after the close on Saturday, as gains in the Consumer Services, Technology and Healthcare sectors led shares higher while losses in the...
Investing.com – U.S. stocks were lower after the close on Friday, as losses in the Healthcare, Oil & Gas and Technology sectors led shares lower. At the close in NYSE, the Dow...
Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) announced that it has completed patient enrollment in the phase III ILLUMINATE-301 study, evaluating tilsotolimod in combination with...
Axovant Gene Therapies Ltd. (NASDAQ:AXGT) announced that the FDA has granted an Orphan Drug designation to its investigational gene therapy candidate, AXO-AAV-GM1, being...
As of late, it has definitely been a great time to be an investor in Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) . The stock has moved higher by 25% in the past month, while it is...
Idera Pharmaceuticals, Inc. is a biopharmaceutical company that is focused on the clinical development, and commercialization of drug candidates for rare diseases and oncology. The Company designed and is developing tilsotolimod, an investigational Toll-like receptor 9 agonist, for the treatment of advanced solid tumors. Its lead investigational product, tilsotolimod, demonstrated activity in various pre-clinical models and is in clinical development across several oncology indications. These indications include anti-PD-1 refractory advanced melanoma, microsatellite-stable colorectal cancer (MSS-CRC, phase II), and recurrent/metastatic head & neck squamous cell carcinoma (HNSCC, phase I/II). Tilsotolimod is used for the treatment of anti-PD-1 refractory melanoma, in combination with ipilimumab, as well as for the treatment of stage IIb-IV melanoma. Its clinical trials include ILLUMINATE-204, ILLUMINATE-206 and ILLUMINATE-101.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Sell |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Sell |
| Summary | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 128.60 | 143.70 | 128.10 | +0.14 | +0.11% | 4.61M | NYSE | |||
| 8.21 | 8.24 | 8.11 | +0.17 | +2.05% | 3.32M | NASDAQ | |||
| 0.1865 | 0.1914 | 0.1861 | -0.0005 | -0.27% | 707.94K | NYSE | |||
| 100.76 | 102.40 | 99.39 | +2.01 | +2.04% | 62.32M | NASDAQ | |||
| 40.50 | 40.67 | 39.58 | +0.92 | +2.32% | 4.15M | NYSE | |||
| 61.50 | 61.50 | 61.48 | 0.00 | 0.00% | 0.00 | NYSE | |||
| 8.30 | 8.55 | 8.31 | -0.01 | -0.06% | 2.49M | NYSE | |||
| 5.13 | 5.14 | 5.07 | +0.040 | +0.79% | 12.96M | NYSE | |||
| 145.30 | 146.34 | 136.59 | +9.50 | +7.00% | 4.05M | NASDAQ | |||
| 1.22 | 1.25 | 1.20 | +0.0300 | +2.52% | 3.26M | NYSE | |||
| 83.25 | 83.40 | 82.10 | +1.36 | +1.66% | 2.25M | NYSE | |||
| 4.44 | 4.47 | 4.44 | 0.000 | 0.00% | 0.00 | NYSE | |||
| 1.52 | 1.52 | 1.52 | +0.0700 | +4.83% | 3.50K | NYSE | |||
| 51.44 | 52.82 | 50.45 | +0.42 | +0.82% | 1.49M | NASDAQ | |||
| 21.42 | 21.72 | 21.07 | +0.36 | +1.71% | 446.07K | NYSE |